Atlas Trials

Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas

Clinical trial NCT00948688 · TERMINATED

Trial details

NCT number
NCT00948688
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic CancerAdenocarcinoma of the Pancreas
Start date
2009-08-01
Primary completion
2012-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.